 Donald Penning
Concepts (152)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cesarean Section | 4 | 2013 | 200 | 1.100 |
Why?
| | Analgesia, Obstetrical | 3 | 2013 | 25 | 0.860 |
Why?
| | Operating Rooms | 4 | 2019 | 132 | 0.760 |
Why?
| | Nerve Block | 2 | 2013 | 83 | 0.720 |
Why?
| | Morphine | 2 | 2013 | 167 | 0.720 |
Why?
| | Elective Surgical Procedures | 4 | 2019 | 190 | 0.610 |
Why?
| | Appointments and Schedules | 1 | 2019 | 95 | 0.580 |
Why?
| | Intraoperative Complications | 2 | 2020 | 146 | 0.560 |
Why?
| | Craniotomy | 1 | 2018 | 79 | 0.550 |
Why?
| | Anesthesiology | 1 | 2019 | 116 | 0.540 |
Why?
| | Endoscopy, Gastrointestinal | 1 | 2019 | 230 | 0.520 |
Why?
| | Obesity, Morbid | 1 | 2020 | 269 | 0.500 |
Why?
| | Analgesics, Opioid | 2 | 2013 | 1076 | 0.430 |
Why?
| | Pain, Postoperative | 2 | 2013 | 298 | 0.410 |
Why?
| | Fetal Blood | 2 | 2005 | 335 | 0.390 |
Why?
| | Hypoxia | 1 | 2018 | 1137 | 0.340 |
Why?
| | Nasal Cavity | 2 | 2020 | 57 | 0.320 |
Why?
| | Epinephrine | 2 | 2020 | 146 | 0.310 |
Why?
| | Paranasal Sinuses | 2 | 2020 | 82 | 0.310 |
Why?
| | Blood Gas Analysis | 2 | 2005 | 82 | 0.290 |
Why?
| | Radiography, Thoracic | 1 | 2008 | 169 | 0.270 |
Why?
| | Medical Errors | 1 | 2008 | 113 | 0.270 |
Why?
| | Intubation, Intratracheal | 1 | 2008 | 265 | 0.250 |
Why?
| | Emergencies | 1 | 2005 | 171 | 0.220 |
Why?
| | Propofol | 1 | 2023 | 86 | 0.190 |
Why?
| | Extracellular Vesicles | 1 | 2023 | 148 | 0.170 |
Why?
| | RNA, Long Noncoding | 1 | 2023 | 173 | 0.170 |
Why?
| | Decision Making | 2 | 2005 | 944 | 0.170 |
Why?
| | Hemostasis, Surgical | 1 | 2020 | 23 | 0.170 |
Why?
| | Pain Measurement | 2 | 2013 | 539 | 0.160 |
Why?
| | Nasal Polyps | 1 | 2020 | 61 | 0.160 |
Why?
| | Tidal Volume | 1 | 2020 | 101 | 0.160 |
Why?
| | Paranasal Sinus Diseases | 1 | 2019 | 16 | 0.160 |
Why?
| | Glioblastoma | 1 | 2023 | 341 | 0.160 |
Why?
| | Nurse Anesthetists | 1 | 2019 | 5 | 0.160 |
Why?
| | Anesthesiologists | 1 | 2019 | 38 | 0.150 |
Why?
| | Blood Loss, Surgical | 1 | 2019 | 104 | 0.150 |
Why?
| | Glioma | 1 | 2023 | 403 | 0.150 |
Why?
| | Emergency Medical Services | 1 | 2005 | 562 | 0.150 |
Why?
| | Leukocytosis | 1 | 2018 | 33 | 0.140 |
Why?
| | Anesthesia, Obstetrical | 2 | 2011 | 22 | 0.140 |
Why?
| | Pregnancy | 6 | 2013 | 6836 | 0.140 |
Why?
| | Double-Blind Method | 2 | 2013 | 1946 | 0.140 |
Why?
| | Intracranial Hemorrhages | 1 | 2018 | 89 | 0.140 |
Why?
| | Sinusitis | 1 | 2020 | 232 | 0.140 |
Why?
| | Workload | 1 | 2019 | 163 | 0.140 |
Why?
| | Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2018 | 125 | 0.130 |
Why?
| | Heart Rate | 1 | 2020 | 798 | 0.130 |
Why?
| | Time Factors | 3 | 2019 | 6877 | 0.130 |
Why?
| | Fetal Monitoring | 2 | 2005 | 20 | 0.120 |
Why?
| | Humans | 16 | 2023 | 138651 | 0.110 |
Why?
| | Brain Neoplasms | 1 | 2023 | 1268 | 0.100 |
Why?
| | Infusions, Spinal | 1 | 2013 | 2 | 0.100 |
Why?
| | Abdominal Muscles | 1 | 2013 | 9 | 0.100 |
Why?
| | Prospective Studies | 3 | 2020 | 7639 | 0.100 |
Why?
| | Amides | 1 | 2013 | 96 | 0.100 |
Why?
| | Bacteria | 1 | 2019 | 868 | 0.100 |
Why?
| | Anesthetics, Local | 1 | 2013 | 93 | 0.100 |
Why?
| | Postoperative Nausea and Vomiting | 1 | 2012 | 22 | 0.090 |
Why?
| | Ultrasonography, Interventional | 1 | 2013 | 146 | 0.090 |
Why?
| | Bupivacaine | 1 | 2012 | 34 | 0.090 |
Why?
| | Pruritus | 1 | 2012 | 65 | 0.090 |
Why?
| | Cohort Studies | 2 | 2019 | 5729 | 0.090 |
Why?
| | Adult | 7 | 2020 | 38296 | 0.090 |
Why?
| | Ilium | 1 | 2011 | 29 | 0.090 |
Why?
| | Kaplan-Meier Estimate | 1 | 2013 | 903 | 0.090 |
Why?
| | Drug Administration Schedule | 1 | 2012 | 769 | 0.080 |
Why?
| | Administration, Intranasal | 2 | 2020 | 91 | 0.080 |
Why?
| | Vasoconstrictor Agents | 2 | 2020 | 133 | 0.080 |
Why?
| | Lumbar Vertebrae | 1 | 2011 | 248 | 0.080 |
Why?
| | Postoperative Complications | 1 | 2020 | 2701 | 0.070 |
Why?
| | Fluoroscopy | 1 | 2008 | 165 | 0.070 |
Why?
| | Patient Satisfaction | 1 | 2012 | 679 | 0.070 |
Why?
| | Young Adult | 3 | 2013 | 13322 | 0.070 |
Why?
| | Age Distribution | 1 | 2008 | 398 | 0.070 |
Why?
| | Lung | 1 | 2020 | 4086 | 0.070 |
Why?
| | Trachea | 1 | 2008 | 251 | 0.060 |
Why?
| | Female | 8 | 2020 | 73913 | 0.060 |
Why?
| | Operating Room Nursing | 2 | 2002 | 7 | 0.060 |
Why?
| | Anesthesia, Spinal | 1 | 2005 | 10 | 0.060 |
Why?
| | Anesthesia, Epidural | 1 | 2005 | 11 | 0.060 |
Why?
| | Ambulatory Surgical Procedures | 2 | 2002 | 70 | 0.060 |
Why?
| | Anesthesia, General | 1 | 2005 | 105 | 0.050 |
Why?
| | Acidosis | 1 | 2005 | 104 | 0.050 |
Why?
| | Fetal Diseases | 1 | 2005 | 175 | 0.050 |
Why?
| | Asphyxia Neonatorum | 1 | 2002 | 18 | 0.050 |
Why?
| | Brain-Derived Neurotrophic Factor | 1 | 2023 | 140 | 0.050 |
Why?
| | Programming, Linear | 1 | 2002 | 1 | 0.050 |
Why?
| | Pregnancy Outcome | 1 | 2005 | 425 | 0.050 |
Why?
| | Hypoxia-Ischemia, Brain | 1 | 2002 | 39 | 0.050 |
Why?
| | Outpatient Clinics, Hospital | 1 | 2002 | 82 | 0.050 |
Why?
| | Neuroprotective Agents | 1 | 2002 | 137 | 0.040 |
Why?
| | Hospital Costs | 1 | 2002 | 119 | 0.040 |
Why?
| | Microglia | 1 | 2023 | 254 | 0.040 |
Why?
| | Drug Administration Routes | 1 | 2020 | 41 | 0.040 |
Why?
| | Progesterone | 1 | 2002 | 258 | 0.040 |
Why?
| | Natural Orifice Endoscopic Surgery | 1 | 2020 | 35 | 0.040 |
Why?
| | Administration, Topical | 1 | 2019 | 148 | 0.040 |
Why?
| | Hemostatic Techniques | 1 | 2019 | 48 | 0.040 |
Why?
| | Neoplastic Stem Cells | 1 | 2023 | 399 | 0.040 |
Why?
| | Infant, Newborn | 2 | 2008 | 6143 | 0.040 |
Why?
| | Dose-Response Relationship, Drug | 2 | 2019 | 2045 | 0.040 |
Why?
| | Cell Survival | 1 | 2002 | 1129 | 0.040 |
Why?
| | Anesthesia | 1 | 2002 | 226 | 0.040 |
Why?
| | Retrospective Studies | 2 | 2008 | 15860 | 0.040 |
Why?
| | Tertiary Care Centers | 1 | 2019 | 170 | 0.040 |
Why?
| | Male | 3 | 2020 | 68216 | 0.030 |
Why?
| | Endoscopy | 1 | 2019 | 320 | 0.030 |
Why?
| | Hemodynamics | 1 | 2020 | 1090 | 0.030 |
Why?
| | Hospitals | 1 | 2019 | 692 | 0.030 |
Why?
| | Infant | 1 | 2008 | 9565 | 0.030 |
Why?
| | Blood Pressure | 1 | 2020 | 1734 | 0.030 |
Why?
| | Child, Preschool | 1 | 2008 | 11130 | 0.030 |
Why?
| | Neurons | 1 | 2002 | 1603 | 0.030 |
Why?
| | Apoptosis | 1 | 2002 | 2558 | 0.030 |
Why?
| | Palpation | 1 | 2011 | 17 | 0.020 |
Why?
| | Adolescent | 2 | 2008 | 21528 | 0.020 |
Why?
| | Florida | 1 | 2011 | 112 | 0.020 |
Why?
| | Prognosis | 1 | 2019 | 4015 | 0.020 |
Why?
| | Child | 2 | 2008 | 21883 | 0.020 |
Why?
| | Patient Positioning | 1 | 2011 | 69 | 0.020 |
Why?
| | Observer Variation | 1 | 2011 | 351 | 0.020 |
Why?
| | Linear Models | 1 | 2011 | 856 | 0.020 |
Why?
| | Ultrasonography | 1 | 2011 | 766 | 0.020 |
Why?
| | Predictive Value of Tests | 1 | 2011 | 2039 | 0.010 |
Why?
| | Treatment Outcome | 1 | 2019 | 10938 | 0.010 |
Why?
| | Reproducibility of Results | 1 | 2011 | 3311 | 0.010 |
Why?
| | Carbocyanines | 1 | 2002 | 33 | 0.010 |
Why?
| | Neurotoxins | 1 | 2002 | 29 | 0.010 |
Why?
| | Dizocilpine Maleate | 1 | 2002 | 24 | 0.010 |
Why?
| | N-Methylaspartate | 1 | 2002 | 42 | 0.010 |
Why?
| | Excitatory Amino Acid Agonists | 1 | 2002 | 41 | 0.010 |
Why?
| | In Situ Nick-End Labeling | 1 | 2002 | 126 | 0.010 |
Why?
| | L-Lactate Dehydrogenase | 1 | 2002 | 127 | 0.010 |
Why?
| | Accounting | 1 | 2002 | 2 | 0.010 |
Why?
| | Excitatory Amino Acid Antagonists | 1 | 2002 | 104 | 0.010 |
Why?
| | Planning Techniques | 1 | 2002 | 18 | 0.010 |
Why?
| | United States | 1 | 2019 | 15018 | 0.010 |
Why?
| | Pregnanolone | 1 | 2002 | 40 | 0.010 |
Why?
| | Cell Count | 1 | 2002 | 324 | 0.010 |
Why?
| | Membrane Potentials | 1 | 2002 | 282 | 0.010 |
Why?
| | Health Care Rationing | 1 | 2002 | 62 | 0.010 |
Why?
| | Middle Aged | 2 | 2019 | 33792 | 0.010 |
Why?
| | Benzimidazoles | 1 | 2002 | 175 | 0.010 |
Why?
| | Costs and Cost Analysis | 1 | 2002 | 220 | 0.010 |
Why?
| | Canada | 1 | 2002 | 412 | 0.010 |
Why?
| | Fluorescent Dyes | 1 | 2002 | 320 | 0.010 |
Why?
| | Tumor Cells, Cultured | 1 | 2002 | 949 | 0.010 |
Why?
| | Length of Stay | 1 | 2002 | 1229 | 0.010 |
Why?
| | Mitochondria | 1 | 2002 | 958 | 0.010 |
Why?
| | Algorithms | 1 | 2002 | 1718 | 0.010 |
Why?
| | Aged | 1 | 2002 | 24182 | 0.000 |
Why?
|
|
Penning's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|